Growth hormone binding protein and acid labile subunit levels in the assessment of acromegaly treatment.

Hormones (Athens, Greece)

Volumn 4, Issue 3, 2005, Pages 148-154

  Tzanela, Marinella ^a   Christoforaki, Marieta ^a   Papastathopoulou, Lida ^a   Vassiliadi, Dimitra ^a   Botoula, Effie ^a   Trivizas, Panagiotis ^a   Thalassinos, Nikos C ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARRIER PROTEIN; DRUG DERIVATIVE; GROWTH HORMONE; SOMATOSTATIN; SOMATOTROPIN BINDING PROTEIN; SOMATOTROPIN-BINDING PROTEIN;

ACROMEGALY; ARTICLE; CRANIOTOMY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ACROMEGALY; BIOLOGICAL MARKERS; CARRIER PROTEINS; CRANIOTOMY; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; TREATMENT OUTCOME;

EID: 33646559188     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.11152     Document Type: Article

References (0)